Development of anti-diabetic agents based on investigating the mechanism of the onset of type 2 diabetes due to protein glycosilation
Development of anti-diabetic agents based on investigating the mechanism of the onset of type 2 diabetes due to protein glycosilation
批准号:
18590517
负责人:
YASUI Hiroyuki
金额:
$2.57万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2006
资助国家:
日本
项目状态:
已结题
起止时间:
2006 至 2007
中文摘要
在丝氨酸或苏氨酸残基上,有许多O-连接的N-乙酰氨基葡萄糖(O-GlcNAc)部分修饰的非核蛋白和细胞质蛋白。我们认为这种O-GlcNAc修饰(丹宁O-GlcN酰化)是一种调节性修饰,类似于磷酸化,即封顶潜在的磷酸化位点。O-GlcNAc转移酶(OGT)是一种负责蛋白质O-GlcN酰化的酶。己糖胺生物合成途径在胰岛素抵抗的诱导过程中起着重要作用。在这一途径中,谷氨酰胺:果糖-6-磷酸氨基转移酶(GFAT)在胰岛素抵抗的发生发展中起着不可或缺的作用。OGT酶利用胞质尿苷二磷酸-N-乙酰氨基葡萄糖(UDP-GlcNAc),它是在氨基己糖生物合成途径中合成的。患有糖尿病和高血糖的动物表现出包括UDP-GlcNAc在内的氨基己糖代谢物浓度显著增加。这种氨基己糖生物合成的增加可以刺激OGT的活性,包括对参与葡萄糖运输系统或颗粒分泌的蛋白质进行O-GlcNAc修饰。因此,高血糖的影响可能是由于O-GlcN酰化异常所致。本研究以链脲佐菌素(STZ)诱导的糖尿病小鼠和3T3-L1细胞为模型,研究了钒、锌、锰等金属络合物对OGT活性的抑制作用和对O-GlcN酰化的影响。结果表明,钒麦芽糖酸相关络合物能够抑制STZ-小鼠器官中蛋白质的O-GlcN酰化。此外,锌化合物能刺激培养的3T3-L1细胞蛋白质去谷氨酰化,但不抑制OGT活性,提示锌化合物可增强O-GlcN酰化蛋白的降解酶O-GlcNAcase活性。
英文摘要
There are many nonle.ar and cytoplasmic proteins that are modified by a single O-linked N-acetylglucosamine (O-GlcNAc) moiety at serine or threonine residues. We proposed that this O-GlcNAc modification (tanned O-GlcNAcylation) is a regulatory modification, analogous to phosphorylation, that is, capping of the potential phosphorylation sites. O-GlcNAc transferase (OGT) is an enzyme responsible for O-GlcNAcylation of proteins. The hexosmine biosynthesis pathway plays an important part in the induction of insulin resistance. In this pathway, glutamine: fructose-6-phosphate amidotransferase (GFAT) has an integral role in the development of insulin resistance. The OGT enzyme uses cytoplasmic uridine diphospho-N-acetylglucosamine (UDP-GlcNAc), which is synthesized in the hexosamine biosynthetic pathway. Animals with diabetes and hyperglycaemia show greatly increased concentrations of hexosamine metabolites including UDP-GlcNAc. This increase in hexosamine biosynthesis could stimulate OGT activity, including O-GlcNAc modification of proteins that are involved in the glucose transport system or in granule secretion. Therefore, it is likely that the effects of hyperglycaemia result from abnormal O-GlcNAcylation. In this study, the effects of metal complexes such as vanadium, zinc, and manganese on the inhibition of OGT activity and on O-GlcNAcylation were investigated in the streptozotocin (STZ)-induced diabetic mice and 3T3-L1 cell lines. As a result, vanadyl-maltolate related complexes were exhibited to suppress the O-GlcNAcylation of proteins in organs of STZ-mice. In addition, zinc compounds were hind to stimulate the de-GlcNAcylation of proteins in the cultured 3T3-L1 cells, without inhibiting the OGT activity, indicating that zinc compounds may enhance the activity of O-GlcNAcase, an degradating enzyme of O-GlcNAcylated proteins.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Improvement of diabetes mellitus and metabolic syndromes in KK-A^y mice by Zn(II) complexeswith Zn(SxOy)coordination modes
Zn(II)配合物与Zn(SxOy)配位模式对KK-A^y小鼠糖尿病和代谢综合征的改善作用
DOI:
--
发表时间:
2007
期刊:
影响因子:
--
作者:
[Yutaka Yoshikawa, AkitoMurayama, Yusuke Adachi, Hiroyuki Yasui, and Hiromu Sakurai]
通讯作者:
and Hiromu Sakurai
Suppressive effect of orally administerd copper(II)-asphinate (Cu_2(asp)_4) complex on the generation of reactive oxygen species in the skin of animals subjected to UVA exposure
口服铜(II)-天冬氨酸(Cu_2(asp)_4)复合物对UVA照射动物皮肤活性氧产生的抑制作用
DOI:
--
发表时间:
2007
期刊:
Exper.Dermatol. 16
影响因子:
--
作者:
[Takako Fujimori, Hiroyuki Yasui, and Hiromu Sakurai]
通讯作者:
and Hiromu Sakurai
Frontier of development of vanadyl and zinc complexes with insulinomimetic activity in Pat hophysiological and Biochemical Analyses of Life-Style Related or Intractable Diseases.
在生活方式相关或难治性疾病的病理生理学和生化分析中具有模拟胰岛素活性的氧钒和锌复合物的发展前沿。
DOI:
--
发表时间:
2006
期刊:
影响因子:
--
作者:
[Hiromu Sakurai, Yusuke Adachi, Kojiro Tayama, Yutaka Yoshikawa, Hiroyuki Yasui, Asuka Tamura, Toshikazu Takino, Akira Katoh]
通讯作者:
Akira Katoh
Orally-active Zn(II) complex with potent anti-diabetic action(1) : -bis(1-oxy-2-pyridinethiolato) zinc(11) complex-
具有有效抗糖尿病作用的口服活性 Zn(II) 复合物(1) : -双(1-氧基-2-吡啶硫基)锌(11) 复合物-
DOI:
--
发表时间:
2007
期刊:
影响因子:
--
作者:
[Akito Murayama, Yutaka Yoshikawa. Yusuke Adachi, Hiroyuki Yasui, Hiromu Sakurai]
通讯作者:
Hiromu Sakurai
抗糖尿病作用を有する経口投与可能な高活性亜鉛錯体(2)-bis(dithiocarbamato)zinc(II)complex-
高活性口服锌络合物 (2)-双(二硫代氨基甲酸)锌(II)络合物-具有抗糖尿病作用
DOI:
--
发表时间:
2007
期刊:
影响因子:
--
作者:
[吉川 豊, 安達 祐介, 安井 裕之, 桜井 弘]
通讯作者:
桜井 弘
共 28 条
Development of anti-diabetic zinc medicine protecting the pancreatic B cells through the GPR39-stimulating Pdx-1 expression
-
批准号:23590653
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$3.33万
-
财政年份:2011
-
负责人:YASUI Hiroyuki
-
依托单位:
Development of inorganic zinc-containing medicines with anti-obesity action
-
批准号:20590551
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$3.08万
-
财政年份:2008
-
负责人:YASUI Hiroyuki
-
依托单位:
Study on development of anti-septic zinc(II) complex with immune-enhancing activity
-
批准号:16590444
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.3万
-
财政年份:2004
-
负责人:YASUI Hiroyuki
-
依托单位:
海外基金